You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 65 No. 4, April 2008 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Neurological Review
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Movement Disorders
 •Multiple Sclerosis/ Demyelinating Disease
 •Parkinson Disease/ Parkinsonian Disorders
 •Review
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Changing Face of Neural Stem Cell Therapy in Neurologic Diseases

Ofira Einstein, PhD; Tamir Ben-Hur, MD, PhD

Arch Neurol. 2008;65(4):452-456.

New insights into the biology of neural stem cells (NSCs) have raised expectations for their use in the treatment of neurologic diseases. Originally, NSC transplantation was proposed as a means of replacing cells in central nervous system diseases that result in cell loss. However, recent data regarding their beneficial effects in various animal models of neurologic diseases indicate that transplanted NSCs may also attenuate deleterious inflammation, protect the central nervous system from degeneration, and enhance endogenous recovery processes. Herein, we review recent developments and future prospects of NSC therapy in neurologic diseases.


Author Affiliations: Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stem cells as therapeutic vehicles for the treatment of high-grade gliomas
Binello and Germano
Neuro Oncol 2011;0:nor204v1-nor204.
ABSTRACT | FULL TEXT  

Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages
London et al.
JEM 2011;208:23-39.
ABSTRACT | FULL TEXT  

Hydrogel Matrix to Support Stem Cell Survival After Brain Transplantation in Stroke
Zhong et al.
Neurorehabil Neural Repair 2010;24:636-644.
ABSTRACT  

Hematopoietic Stem Cell Transplantation: A Global Perspective
Gratwohl et al.
JAMA 2010;303:1617-1624.
ABSTRACT | FULL TEXT  

Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells
Calza et al.
J Mol Endocrinol 2010;44:13-23.
ABSTRACT | FULL TEXT  

Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration
Einstein et al.
J. Neurosci. 2009;29:15694-15702.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.